Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers.
about
PTEN genomic deletion defines favorable prognostic biomarkers in localized prostate cancer: a systematic review and meta-analysis.Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all?Optimized multiparametric flow cytometric analysis of circulating endothelial cells and their subpopulations in peripheral blood of patients with solid tumors: a technical analysis.
P2860
Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tumor vascularity in prostate ...... ets as noninvasive biomarkers.
@en
type
label
Tumor vascularity in prostate ...... ets as noninvasive biomarkers.
@en
prefLabel
Tumor vascularity in prostate ...... ets as noninvasive biomarkers.
@en
P2860
P356
P1476
Tumor vascularity in prostate ...... lets as noninvasive biomarkers
@en
P2093
Niall Corcoran
Nikhil Sapre
P2860
P304
P356
10.2217/BMM.13.100
P577
2013-12-01T00:00:00Z